DW30
WST icon

Drucker Wealth 3.0’s West Pharmaceutical WST Stock Holding History

Drucker Wealth 3.0’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$308K Sell
857
-3
-0.3% -$917 0.05% 225
2026
Q1 		$216K Sell
860
-18
-2% -$4.48K 0.04% 249
2025
Q4 		$242K Sell
878
-108
-11% -$29.5K 0.04% 234
2025
Q3 		$259K Buy
+986
New +$240K 0.05% 221

Other funds holding WST

RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
SIM
Seilern Investment Management London, United Kingdom $794M AUM 6.63% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
GWI
Grace & White Inc Ny, New York $632M AUM 34.34% 1-Year Est. Return
MCG
McCollum Christoferson Group Amherst, New York $341M AUM 15.01% 1-Year Est. Return
YCM
Yousif Capital Management Bloomfield Hills, Michigan $8.94B AUM 42.6% 1-Year Est. Return
BZWA
Blue Zone Wealth Advisors Los Angeles, California $573M AUM 22.86% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Drucker Wealth 3.0's WST Position: Q2 2026 in Review

Drucker Wealth 3.0 reduced its West Pharmaceutical (WST) stake by 0.35% in Q2 2026, selling an estimated $917 and leaving 857 shares worth $308K. The position accounts for 0.05% of the portfolio, ranked #225.

Drucker Wealth 3.0 first reported a position in WST in Q3 2025 and has held it in 4 quarters since. 120 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • Drucker Wealth 3.0 held 857 shares of West Pharmaceutical worth $308K as of Q2 2026.
  • Drucker Wealth 3.0 sold 3 West Pharmaceutical shares in Q2 2026, an estimated $917.
  • West Pharmaceutical made up 0.05% of Drucker Wealth 3.0's portfolio in Q2 2026, its #225 holding.
  • Drucker Wealth 3.0 first reported a position in West Pharmaceutical in Q3 2025 and has held it in 4 quarters since.
  • 120 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Drucker Wealth 3.0's 13F filing for Q2 2026, filed 13 Jul 2026.